Shawn Titcomb
Director/Board Member at Praesidia Biotherapeutics, Inc.
Net worth: 3 M $ as of 2024-04-29
Profile
Shawn M.
Titcomb was the founder of ZyVersa Therapeutics Operating, Inc. founded in 2014, where he held the title of Chairman.
Currently, he is an Independent Director at Praesidia Biotherapeutics, Inc. since 2021.
Previously, he worked as a Managing Director at Noble Capital Markets, Inc. from 2000 to 2012.
He also served as a Director at Coya Therapeutics, Inc., a Partner at Variant Trading Institutional Group, Inc., and a Vice President at Avalon Research Group, Inc. Mr. Titcomb obtained his undergraduate degree from the University of Denver.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
COYA THERAPEUTICS, INC.
2.30% | 2022-12-28 | 333,826 ( 2.30% ) | 3 M $ | 2024-04-29 |
Shawn Titcomb active positions
Companies | Position | Start |
---|---|---|
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Director/Board Member | 2021-06-30 |
Former positions of Shawn Titcomb
Companies | Position | End |
---|---|---|
Noble Capital Markets, Inc.
Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Corporate Officer/Principal | - |
COYA THERAPEUTICS, INC. | Director/Board Member | - |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Founder | - |
Avalon Research Group, Inc. | Sales & Marketing | - |
Variant Trading Institutional Group, Inc.
Variant Trading Institutional Group, Inc. Investment Banks/BrokersFinance Variant Trading Institutional Group, Inc. operates as a brokerage firm. It specializes in the business of buying and selling securities such as stocks, bonds, mutual funds and other investment products. The company was founded in 2003 and is headquartered in Boca Raton, FL. | Sales & Marketing | - |
Training of Shawn Titcomb
University of Denver | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
COYA THERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Variant Trading Institutional Group, Inc.
Variant Trading Institutional Group, Inc. Investment Banks/BrokersFinance Variant Trading Institutional Group, Inc. operates as a brokerage firm. It specializes in the business of buying and selling securities such as stocks, bonds, mutual funds and other investment products. The company was founded in 2003 and is headquartered in Boca Raton, FL. | Finance |
Avalon Research Group, Inc. | Finance |
Noble Capital Markets, Inc.
Noble Capital Markets, Inc. Investment Banks/BrokersFinance Founded in 1984, Noble Financial Capital Markets is a broker/dealer headquartered in Boca Raton, Florida. The firm is a subsidiary of Noble Financial Group, Inc. Noble Financial Capital Markets' sales & trading team provides strategic insight and reliable solutions to nearly 500 of the dominant small-cap money managers in North America. They are members FINRA, SIPC and MSRB. Noble Financial Capital Markets offers a full array of investment services with a particular focus on under-followed, undervalued, out-of-favor small-cap emerging growth companies. Their research coverage universe includes healthcare, business services & software, defense/defense technology, energy, enterprise hardware, and media & entertainment. | Finance |
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | Health Services |
- Stock Market
- Insiders
- Shawn Titcomb